Sifei Han

机构：China Pharmaceutical University, Monash University · ORCID：0000-0001-7433-3711

发表论文 36 篇 · 总被引 2457 次 · h-index 18

代表论文

• Antibody drug conjugate: the “biological missile” for targeted cancer therapy (2022 · Signal Transduction and Targeted Therapy · 被引 1586)
• Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations (2017 · Journal of Pharmaceutical Sciences · 被引 62)
• Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations (2018 · Molecular Pharmaceutics · 被引 60)
• Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles (2021 · Pharmaceutical Research · 被引 50)
• Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties (2019 · Molecular Pharmaceutics · 被引 45)
• Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans (2020 · Frontiers in Physiology · 被引 39)